3 Cryo-EM density map
A small clinical trial confirmed these findings, showing that exenatide, another GLP-1 agonist, significantly reduced intracranial pressure in patients with idiopathic intracranial hypertension, greatly improving headache symptoms
After reviewing five eligible randomized clinical trials involving 497 total participants, the authors found that berberine and silymarin coadministration could lead to an "advantageous improvement in lipid and glucose profile" namely, it could lower total cholesterol, low-density lipoprotein ("bad") cholesterol, and triglycerides while increasing high-density lipoprotein ("good") cholesterol.43 Such impacts are why berberine may be particularly useful to people with type 2 diabetes
Prioritising nutrient-dense foods will help support overall health and well-being
Real-world studies have confirmed these results: a 2025 study published in Diabetes, Obesity and Metabolism found tirzepatide was associated with greater weight loss over 6 months than semaglutide in patients without diabetes, consistent with the trial data